» Articles » PMID: 30428461

In-Hospital Mortality and Major Adverse Cardiovascular Events After Kidney Transplantation in the United States

Overview
Journal Cardiorenal Med
Publisher Karger
Date 2018 Nov 15
PMID 30428461
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Kidney transplantation (KT) is the treatment of choice for end-stage kidney disease. Cardiovascular disease is a major determinant of morbidity and mortality in patients with KT. Temporal trends in perioperative cardiovascular outcomes after KT are understudied, especially in light of an aging KT waitlist population.

Methods: We performed a retrospective observational cohort study using the National Inpatient Sample for the years 2004-2013. All adult patients undergoing KT were identified using the appropriate International Classification of Diseases, 9th Revision, Clinical Modification codes. Demographic and hospital characteristics, discharge disposition, payer status, and major adverse cardiovascular events (MACEs) were summarized using summary statistics. Multivariate logistic regression was used to identify predictors of MACEs in the perioperative period of KT.

Results: A total of 147,431 KTs were performed between 2004 and 2013. The mean age at KT went up from 48.1 to 51.8 years from 2004 to 2013. Medicare was the primary payer for 59.6% of the KTs. Overall average perioperative mortality was 0.5%, median length of stay was 5 days, and 6.5% of patients experienced an MACE, 78% of which were heart failures (HFs). Important predictors of perioperative MACEs were age ≥65 years (OR = 2.14), Medicare as primary payer (OR = 1.51), diabetes (OR = 1.46), recreational drug use (OR = 1.72), pulmonary circulation disorders (OR = 3.28), and malnutrition (OR = 1.91).

Conclusion: Despite increases in age at the time of KT, the absolute risk of perioperative MACEs has remained stable from 2004 to 2013. HF is a major component of postoperative MACEs in KT. Malnutrition and pulmonary hypertension are major nontraditional predictors of perioperative MACE outcomes.

Citing Articles

Heart failure medication use and follow-up patterns in renal transplant recipients with reduced ejection fraction: A single-center experience.

Hill M, Legg K, Ardati A, Groo V Int J Cardiol Heart Vasc. 2024; 55:101535.

PMID: 39483150 PMC: 11525616. DOI: 10.1016/j.ijcha.2024.101535.


Identification of Novel Independent Correlations between Cellular Components of the Immune System and Strain-Related Indices of Myocardial Dysfunction in CKD Patients and Kidney Transplant Recipients without Established Cardiovascular Disease.

Duni A, Kitsos A, Bechlioulis A, Lakkas L, Markopoulos G, Tatsis V Int J Mol Sci. 2024; 25(17).

PMID: 39273110 PMC: 11395156. DOI: 10.3390/ijms25179162.


Influence of diabetes and other risk factors on in-hospital mortality following kidney transplantation: an analysis of the Spanish National Hospital Discharge Database from 2016 to 2020.

Lopez-de-Andres A, Jimenez-Garcia R, Lopez-Herranz M, Zamorano-Leon J, Carabantes-Alarcon D, Hernandez-Barrera V BMJ Open Diabetes Res Care. 2024; 12(2).

PMID: 38575154 PMC: 11002393. DOI: 10.1136/bmjdrc-2023-003799.


Trends in kidney transplantation and living donor nephrectomy in Germany: a total population analysis from 2006 to 2021.

Zacharis A, Reimold P, Aksoy C, Jung J, Martin T, Eisenmenger N World J Urol. 2024; 42(1):24.

PMID: 38198066 PMC: 10781803. DOI: 10.1007/s00345-023-04737-w.


Screening for occult coronary artery disease in potential kidney transplant recipients: time for reappraisal?.

Ferro C, Berry M, Moody W, George S, Sharif A, Townend J Clin Kidney J. 2021; 14(12):2472-2482.

PMID: 34950460 PMC: 8690093. DOI: 10.1093/ckj/sfab103.